FDA Inspection
ARNA Pharma Pty., Ltd.ARNA Pharma Pty., Ltd. – FDA Inspection, Oct 17, 2025
Record Details
This FDA Inspection record concerns ARNA Pharma Pty., Ltd., with an inspection on October 17, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 9b8d027e-c374-4b0f-ab14-c27618e3b54f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1288492
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ARNA Pharma Pty., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 17, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2018 | Not classified | Office of Inspections and Investigations | |
| September 21, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 16, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ARNA Pharma Pty., Ltd.
- FDA Inspection 1089805 - 2019-05-17
- FDA Inspection 1069444 - 2018-08-03
- FDA Inspection 804043 - 2012-09-21
- FDA Inspection 623897 - 2009-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.